37th week of 2019 patent applcation highlights part 23 |
Patent application number | Title | Published |
20190276453 | BRUTON'S TYROSINE KINASE INHIBITORS | 2019-09-12 |
20190276454 | Spirocentric Compounds and Polymers Thereof | 2019-09-12 |
20190276455 | CRYSTALLINE FORM OF GNRH RECEPTOR ANTAGONIST AND PREPARATION METHOD THEREFOR | 2019-09-12 |
20190276456 | 4-IMIDAZOPYRIDAZIN-1-YL-BENZAMIDES AS BTK INHIBITORS | 2019-09-12 |
20190276457 | Pyrazolo[4,3-d]pyrimidines as Antitumor Agents | 2019-09-12 |
20190276458 | Substituted Fused Pyrrolo-Diazepinones and Uses Thereof | 2019-09-12 |
20190276459 | MODULATORS OF BTK PROTEOLYSIS AND METHODS OF USE | 2019-09-12 |
20190276461 | SELECTIVE BRUTON'S TYROSINE KINASE INHIBITOR AND USE THEREOF | 2019-09-12 |
20190276462 | [1,2,4]TRIAZOLO[1,5‐A]PYRIMIDINE COMPOUNDS AS PDE2 INHIBITORS | 2019-09-12 |
20190276463 | GSK-3 INHIBITORS | 2019-09-12 |
20190276464 | Novel Pharmaceutical Intermediates and Methods for Preparing the Same | 2019-09-12 |
20190276465 | Nitrogen-Containing Heterocyclic Compounds As FXR Modulators | 2019-09-12 |
20190276466 | TRICYCLIC RHO KINASE INHIBITORS | 2019-09-12 |
20190276467 | Substituted indole compound derivatives as dengue viral replication inhibitors | 2019-09-12 |
20190276468 | ANTIVIRAL COMPOUNDS | 2019-09-12 |
20190276469 | Cyclic Ketals As Fragrance Precursor Compounds | 2019-09-12 |
20190276470 | PROCESS FOR PREPARATION OF ERIBULIN AND INTERMEDIATES THEREOF | 2019-09-12 |
20190276471 | INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHOD OF THEIR USE | 2019-09-12 |
20190276472 | 1,1,1-TRIFLUORO-3-HYDROXYPROPAN-2-YL CARBAMATE DERIVATIVES AS MAGL INHIBITORS | 2019-09-12 |
20190276473 | 2-Oxo-Thiazole Derivatives as A2A Inhibitors and Compounds for Use in the Treatment of Cancers | 2019-09-12 |
20190276474 | CHIMERIC COMPOUNDS TARGETING PROTEINS, COMPOSITIONS, METHODS, AND USES THEREOF | 2019-09-12 |
20190276475 | CRYSTAL AND SALT OF NITROIMIDAZOLE, AND MANUFACTURING METHOD THEREOF | 2019-09-12 |
20190276476 | TWO-DIMENSIONAL METAL-ORGANIC-FRAMEWORKS | 2019-09-12 |
20190276477 | Metal Complexes Containing Cyclopentadienyl Ligands | 2019-09-12 |
20190276478 | HETEROARYLTRIFLUOROBORATE COMPOUNDS FOR THE TREATMENT OF MYCOBACTERIAL INFECTIONS | 2019-09-12 |
20190276479 | PROCESS FOR THE PRODUCTION OF TRIARYL ORGANOBORATES | 2019-09-12 |
20190276480 | PROCESSES FOR PREPARING PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS | 2019-09-12 |
20190276481 | Liver Prodrugs of Mitochondrial Proton Ionophores | 2019-09-12 |
20190276482 | PHOTO ACTIVE AGENTS | 2019-09-12 |
20190276483 | PRODRUGS OF PYRIDONE AMIDES USEFUL AS MODULATORS OF SODIUM CHANNELS | 2019-09-12 |
20190276484 | COMPOSITIONS AND METHODS COMPRISING OSMIUM FOR THE TREATMENT OF CANCERS | 2019-09-12 |
20190276485 | BLUE AND NARROW BAND GREEN AND RED EMITTING METAL COMPLEXES | 2019-09-12 |
20190276486 | PLATINUM COMPLEX, ITS PREPARATION AND THERAPEUTIC USE | 2019-09-12 |
20190276487 | DEVICE AND CASSETTE FOR PERFORMING A PLURALITY OF SYNTHESIS PROCESSES OF PREPARING A RADIOPHARMACEUTICAL IN SERIES | 2019-09-12 |
20190276488 | ADENOSINE ANALOGS AS METHYLTRANSFERASE INHIBITORS FOR TREATING CANCER | 2019-09-12 |
20190276489 | PROGESTERONE ANALOGS AND USES RELATED THERETO | 2019-09-12 |
20190276490 | METHODS FOR THE IODINATION OF BIOMOLECULES | 2019-09-12 |
20190276491 | Chromatography Medium | 2019-09-12 |
20190276492 | FC-RECEPTOR BASED AFFINITY CHROMATOGRAPHY | 2019-09-12 |
20190276493 | PROCESS FOR THE PREPARATION OF 1,5-BENZOTHIAZEPINE COMPOUNDS | 2019-09-12 |
20190276494 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF MITOCHONDRIAL MYOPATHIES | 2019-09-12 |
20190276495 | EBOLA VIRUS VACCINE | 2019-09-12 |
20190276496 | FOXP3-BINDING PEPTIDES AND USES THEREOF | 2019-09-12 |
20190276497 | Cyclopeptide, pharmaceutical or cosmetic composition comprising the same and method for preparing the same | 2019-09-12 |
20190276498 | CYTOMEGALOVIRUS ANTIGENS AND USES THEREOF | 2019-09-12 |
20190276499 | Protein VII Fragments and Methods of Use Thereof for the Treatment of Inflammatory Disorders | 2019-09-12 |
20190276500 | HETEROLOGOUS EXPRESSION CASSETTE, DNA CONSTRUCT AND VACCINE COMPOSITION TO IMMUNIZE AGAINST FLAVIVIRUS AND/OR OTHER PATHOGENS | 2019-09-12 |
20190276501 | ENGINEERED MICROCOMPARTMENT PROTEIN AND RELATED METHODS AND SYSTEMS OF ENGINEERING BACTERIAL SYSTEMS FOR NON-NATIVE PROTEIN EXPRESSION AND PURIFICATION | 2019-09-12 |
20190276502 | FUSION POLYPEPTIDES DERIVED FROM STAPHYLOCOCCUS AUREUS ANTIGENS | 2019-09-12 |
20190276503 | ARTIFICIALLY ENGINEERED SC FUNCTION CONTROL SYSTEM | 2019-09-12 |
20190276504 | Walnut Oligopeptide Powder, Preparation Method And Application Thereof | 2019-09-12 |
20190276505 | ANTIMICROBIAL PEPTIDES COMPRISING EPSILON LYSINE RESIDUES | 2019-09-12 |
20190276506 | COMPOSITIONS COMPRISING CelTOS IMMUNOGENS AND ANTIBODIES AND METHOD OF USE THEREOF | 2019-09-12 |
20190276507 | CODON OPTIMIZED NUCLEIC ACID ENCODING A RETINITIS PIGMENTOSA GTPASE REGULATOR (RPGR) | 2019-09-12 |
20190276508 | METHOD OF PURIFICATION OF RECOMBINANT OSTEOPONTIN FROM MICROALGAE | 2019-09-12 |
20190276509 | AGENTS AND METHODS FOR TREATING CBP-DEPENDENT CANCERS | 2019-09-12 |
20190276510 | USE OF FIBROBLAST GROWTH FACTOR 1 (FGF1)-VAGUS NERVE TARGETING CHIMERIC PROTEINS TO TREAT HYPERGLYCEMIA | 2019-09-12 |
20190276511 | Cytokine Fusion Proteins | 2019-09-12 |
20190276512 | RECOMBINANT CHICKEN INTERLEUKIN-1 BETA PROTEIN FOR PRODUCING ANTIBODY EARLY AND RETAINING FOR A LONGER PERIOD OF TIME AND APPLICATION THEREOF | 2019-09-12 |
20190276513 | SYNTHETIC SOMATOSTATIN RECEPTOR LIGANDS | 2019-09-12 |
20190276514 | THERAPEUTIC AND DIAGNOSTIC CLONED MHC-UNRESTRICTED RECEPTOR SPECIFIC FOR THE MUC1 TUMOR ASSOCIATED ANTIGEN | 2019-09-12 |
20190276515 | COMPOSITION OF FISH SKIN COLLAGEN PEPTIDES AND USE THEREOF AS A DRUG | 2019-09-12 |
20190276516 | ALPHA1 -ANTITRYPSIN COMPOSITIONS AND METHODS OF TREATING AUTOIMMUNE DISEASES | 2019-09-12 |
20190276517 | Methods and Compositions for Treating Melanoma | 2019-09-12 |
20190276518 | THERAPY FOR ENTERIC INFECTIONS | 2019-09-12 |
20190276519 | IMMUNOGENETIC RESTRICTION ON ELICITATION OF ANTIBODIES | 2019-09-12 |
20190276520 | HUMAN ZIKA VIRUS ANTIBODIES AND METHODS OF USE THEREFOR | 2019-09-12 |
20190276521 | THERAPEUTIC AGENT FOR TREATMENT OF AUTOIMMUNE DISEASES CONTAINING ANTIBODY BINDING TO HAPTOGLOBIN IN BLOOD AND FORMING POLYVALENT IMMUNE COMPLEX AS AN ACTIVE COMPONENT | 2019-09-12 |
20190276522 | ANTIBODIES TO ALPHA-SYNUCLEIN AND USES THEREOF | 2019-09-12 |
20190276523 | COMPOSITION AND METHODS OF TREATING B CELL DISORDERS | 2019-09-12 |
20190276524 | EFFICACY OF AN ANTI-C5 ANTIBODY IN THE PREVENTION OF ANTIBODY MEDIATED REJECTION IN SENSITIZED RECIPIENTS OF A KIDNEY TRANSPLANT | 2019-09-12 |
20190276525 | ANTI-NERVE GROWTH FACTOR ANTIBODIES AND METHODS OF PREPARING AND USING THE SAME | 2019-09-12 |
20190276526 | COMPOSITION AND METHOD FOR THE DIAGNOSIS AND TREATMENT OF DISEASES ASSOCIATED WITH NEURITE DEGENERATION | 2019-09-12 |
20190276527 | METHODS FOR ALTERING BODY COMPOSITION | 2019-09-12 |
20190276528 | Stable Aqueous Formulations of Aflibercept | 2019-09-12 |
20190276529 | Local Orbital Therapy for Thyroid Eye Disease | 2019-09-12 |
20190276530 | BLOOD BRAIN BARRIER SHUTTLE | 2019-09-12 |
20190276531 | ANTI-TIM-3 ANTIBODIES AND COMPOSITIONS | 2019-09-12 |
20190276532 | PILR ALPHA INTERACTIONS AND METHODS OF MODIFYING SAME | 2019-09-12 |
20190276533 | ANTI-TIM-3 ANTIBODIES AND USE THEREOF | 2019-09-12 |
20190276534 | ANTI-TIM-3 ANTIBODIES FOR COMBINATION WITH ANTI-PD-1 ANTIBODIES | 2019-09-12 |
20190276535 | ANTIGEN BINDING PROTEINS | 2019-09-12 |
20190276536 | HUMANIZED ANTIBODIES WITH INCREASED STABILITY | 2019-09-12 |
20190276537 | Segregation Modulation for Immunotherapy | 2019-09-12 |
20190276538 | HUMAN ANTIBODIES THAT BIND LYMPHOCYTE ACTIVATION GENE-3 (LAG-3), AND USES THEREOF | 2019-09-12 |
20190276539 | HUMAN ANTIBODIES THAT BIND LYMPHOCYTE ACTIVATION GENE-3 (LAG-3), AND USES THEREOF | 2019-09-12 |
20190276540 | COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS | 2019-09-12 |
20190276541 | GLYCAN-INTERACTING COMPOUNDS AND METHODS OF USE | 2019-09-12 |
20190276542 | ANTI-PD1 AND ANTI-CTLA4 ANTIBODIES | 2019-09-12 |
20190276543 | COMPOSITIONS AND METHODS FOR TREATING LATE STAGE LUNG CANCER | 2019-09-12 |
20190276544 | AFFINITY MATURED ANTI-CCR4 HUMANIZED MONOCLONAL ANTIBODIES AND METHODS OF USE | 2019-09-12 |
20190276545 | CCR3 Inhibition for Ocular Angiogenesis and Macular Degeneration | 2019-09-12 |
20190276546 | METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING BINDING PROTEINS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR) IN COMBINATION WITH GLP-1 AGONISTS | 2019-09-12 |
20190276547 | ANTIBODIES, USES & METHODS | 2019-09-12 |
20190276548 | Anti-NGF Antibodies and Methods Thereof | 2019-09-12 |
20190276549 | POLYPEPTIDE VARIANTS AND USES THEREOF | 2019-09-12 |
20190276550 | Anti-CD79B Antibodies and Immunoconjugates and Methods of Use | 2019-09-12 |
20190276551 | ANTIGEN-BINDING POLYPEPTIDES DIRECTED AGAINST CD38 | 2019-09-12 |
20190276552 | NOVEL BENZODIAZEPINE DERIVATIVES | 2019-09-12 |
20190276553 | ANTI-CD46 ANTIBODIES AND METHODS OF USE | 2019-09-12 |